SOURCE: Syneron Medical Ltd.

Syneron Medical Ltd.

September 15, 2010 16:15 ET

Syneron to Present at UBS Global Life Sciences Conference

YOKNEAM, ISRAEL--(Marketwire - September 15, 2010) -  Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today that the Company will participate in the UBS Global Life Sciences Conference on Tuesday, September 21, 2010, in New York City. Syneron CEO Louis P. Scafuri will present on behalf of the Company at 1:30 pm ET.

The presentation will be Web cast live over the Internet and can be accessed through the Investor Relations section on Syneron's Web site at www.syneron.com. Please go to the Web site a few minutes early, as it may be necessary to download audio software to hear the presentation.

About Syneron Medical Ltd.

Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The Company markets and services and supports its products in 90 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

Additional information can be found at www.syneron.com.

Contact Information